ArticleEBioMedicine2026

Proteomic profiling and molecular reclassification of high-grade serous ovarian cancer identifies prognostic subtypes and immunotherapy biomarkers.

Mengyan Tu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.